Drugmakers and pharmaceutical industry groups urged the US Food and Drug Administration (FDA) to align its classification categories for visible particles with the US Pharmacopoeia’s (USP) Chapter ...
Debates over the presence of microplastics in the human body highlight the challenge of studying something simultaneously ...